Masato Yoshihara

No ORCID on file · 6 papers in corpus · active 2016-2022

Study types

  • article 3
  • review 2
  • rct 1

Condition tags

  • endometriosis 2
  • endometrioma 1
article 2022
Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis
·doi:10.1016/j.matbio.2022.03.003

Ovarian cancer (OvCa), a lethal gynecological malignancy, disseminates to the peritoneum. Mesothelial cells (MCs) act as barriers in the abdominal cavity, preventing the adhesion of cancer cells. However, in patients with OvCa, they are tra…

rct 2021
Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00866-2

BACKGROUND: Ovarian endometrioma is a common gynecological disease that is often treated with surgery or hormonal treatment. Ovarian cystectomy, a surgical procedure for ovarian endometrioma, can result in impaired ovarian reserve. METHODS…

review 2019
Endometriosis and cancer
Free radical biology & medicine ·doi:10.1016/j.freeradbiomed.2018.12.015

Endometriosis, characterized by the presence of extra-uterine endometrium, is a common gynecologic disorder in reproductive-age women. Although the detailed molecular mechanism of etiology remains unelucidated, recent studies have gradually…

article 2017
A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer
·doi:10.3892/or.2017.6104

Epithelial ovarian cancer (EOC) is believed to cause peritoneum dissemination through microenvironmental cell‑to-cell communication between the tumor and mesothelium, leading to the further acquisition of progressive and metastatic potentia…

review 2016
A Case Report and Literature Review of Spontaneous Perforation of Pyometra
·doi:10.1016/j.jemermed.2016.01.024
article 2016
Risk factors for cellulitis in patients with secondary lower limb lymphedema associated with gynecological cancer treatment
·doi:10.1016/j.ejogrb.2016.07.458